NDAQ:NRBO - Post Discussion
Post by
whytestocks on Feb 01, 2024 10:00am
NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a
News; $NRBO NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of ObesityNeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity PR Newswire Preclinical Studies Show DA-1726 Elicits Superior Weight Loss Compared to Semaglutide (Wegovy™) and Similar Weight Loss Compared to Ti...
NRBO - NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity
Be the first to comment on this post